Corcept Therapeutics just got hit with an FDA rejection—but insiders are buying millions and short interest is surging. With a profitable base business and major 2026 catalysts ahead, CORT may be one of the most explosive “binary bets” in biotech today.

Read entire article

Vail Resorts (MTN) just endured one of the worst snowfall seasons in decades—yet insiders are buying millions in stock. With a powerful Epic Pass model, heavy institutional ownership, and rising short interest, this mountain stock may be setting up for a contrarian move.

Read entire article

Gibraltar Industries may not be glamorous, but the company sits at the heart of housing, infrastructure, and agtech. With insider buying, a massive OmniMax acquisition, and valuations near historic lows, ROCK could be one of the market’s most overlooked industrial value plays.

Read entire article

When FOX’s CEO Lachlan Murdoch bought $10 million of his own stock, Wall Street barely blinked. But with institutions owning 109% of the float and live sports dominating advertising markets, FOX might be setting up for one of the most overlooked media squeezes of the decade.

Read entire article

Capri Holdings sold Versace, cleaned up its balance sheet, and now trades near multi-year lows. With insider buying and heavy institutional ownership, investors face a classic question: is CPRI a luxury turnaround or a fading fashion house?

Read entire article

Kosmos Energy insiders just bought millions of dollars of stock after issuing nearly 100 million new shares. Is this a turnaround signal… or a classic case of debt-driven dilution? Let’s break down the risks, the oil assets, and the “sneaky management” dilemma.

Read entire article

Asbury Automotive Group (NYSE: ABG) may be one of the most overlooked value stocks in the market. With the CEO investing over $1M of his own money and institutions owning more than 100% of the float, the setup is intriguing.

Read entire article

Harley-Davidson stock is down more than 75% from its historic highs, but insiders are buying, institutions own over 100% of the float, and short sellers are circling. Is HOG a value trap… or a contrarian opportunity ready to roar?

Read entire article

When insiders start buying stock aggressively, investors take notice. In early 2026, executives, directors, and members of the Scripps family all stepped in to buy SSP shares. The question now: is this a deep-value media turnaround or a value trap?

Read entire article

A new CEO buying $1M in shares is always interesting. But with CSX trading near all-time highs while earnings soften, investors face a classic dilemma: operational confidence vs valuation discipline.

Read entire article